Moleculin Biotech
MBRX
MBRX
29 hedge funds and large institutions have $8.88M invested in Moleculin Biotech in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 0 reducing their positions, and 11 closing their positions.
Holders
29
Holders Change
+3
Holders Change %
+11.54%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
8
Reduced
–
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SCM
1
Sio Capital Management
New York
|
$3.93M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$1.91M |
3 |
3
BlackRock
New York
|
$977K |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$713K |
5 |
5
Northern Trust
Chicago,
Illinois
|
$207K |